SCHEMBL3653276

SCHEMBL3653276

CC(C)(C)OC(=O)N1CCC(O)CC1I

nearest known ligand 0.49

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.49
CHRM1 P11229 1/20 0.49
CHRM3 P20309 1/20 0.49
PREP P48147 2/20 0.42
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.39
USP2 O75604 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
RECQL P46063 1/20 0.36
EPHX1 P07099 1/20 0.36
NR1H2 P55055 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21761369 0.84 CHRM2 (0.43) CHRM2CHRM1CHRM3PREPHPGD
SCHEMBL7958092 0.84 CHRM2 (0.43) CHRM2CHRM1CHRM3PREPHPGD
SCHEMBL2764923 0.83 CHRM2 (0.51) CHRM2CHRM1CHRM3PREPHPGD
SCHEMBL23377566 0.83 CHRM2 (0.47) CHRM2CHRM1CHRM3PREPHPGD
SCHEMBL29947374 0.83 CHRM2 (0.47) CHRM2CHRM1CHRM3PREPHPGD
SCHEMBL9312524 0.82 CHRM2 (0.50) CHRM2CHRM1CHRM3PREPHPGD
SCHEMBL19627636 0.82 CHRM2 (0.50) CHRM2CHRM1CHRM3PREPHPGD
SCHEMBL8934384 0.82 CHRM2 (0.50) CHRM2CHRM1CHRM3PREPHPGD
SCHEMBL19627634 0.82 CHRM2 (0.50) CHRM2CHRM1CHRM3PREPHPGD
SCHEMBL19634252 0.82 CHRM2 (0.50) CHRM2CHRM1CHRM3PREPHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010094643-A1 QUINOLINE DERIVATIVES AND THEIR USES FOR RHINITIS AND URTICARIA GLAXO GROUP LIMITED (GB) 2010-08-26 WO disclosed
EP-2205585-A1 QUINOLINE DERIVATIVES USED TO TREAT INFLAMMATORY AND ALLERGIC DISEASES Glaxo Group Limited (GB) 2010-07-14 EP disclosed
WO-2009050204-A1 QUINOLINE DERIVATIVES USED TO TREAT INFLAMMATORY AND ALLERGIC DISEASES GLAXO GROUP LIMITED (GB) 2009-04-23 WO disclosed